Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 19415468)

1.

Local controlled delivery of anti-neoplastic RNAse to the brain.

Slager J, Tyler B, Shikanov A, Domb AJ, Shogen K, Sidransky D, Brem H.

Pharm Res. 2009 Aug;26(8):1838-46. doi: 10.1007/s11095-009-9893-3. Epub 2009 May 5.

2.

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

Judy KD, Olivi A, Buahin KG, Domb A, Epstein JI, Colvin OM, Brem H.

J Neurosurg. 1995 Mar;82(3):481-6.

PMID:
7861228
3.

Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.

Legnani FG, Pradilla G, Thai QA, Fiorindi A, Recinos PF, Tyler BM, Gaini SM, DiMeco F, Brem H, Olivi A.

J Neurooncol. 2006 May;77(3):225-32.

4.

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

Olivi A, Ewend MG, Utsuki T, Tyler B, Domb AJ, Brat DJ, Brem H.

Cancer Chemother Pharmacol. 1996;39(1-2):90-6.

PMID:
8995504
5.

L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model.

Sipos EP, Witham TF, Ratan R, Burger PC, Baraban J, Li KW, Piantadosi S, Brem H.

Neurosurgery. 2001 Feb;48(2):392-400.

PMID:
11220384
6.

Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.

Pradilla G, Legnani FG, Petrangolini G, Francescato P, Chillemi F, Tyler BM, Gaini SM, Brem H, Olivi A, DiMeco F.

Neurosurgery. 2005 Nov;57(5):1032-40; discussion 1032-40.

7.

Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.

Menei P, Boisdron-Celle M, Croué A, Guy G, Benoit JP.

Neurosurgery. 1996 Jul;39(1):117-23; discussion 123-4.

PMID:
8805147
8.

Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.

Brem S, Tyler B, Li K, Pradilla G, Legnani F, Caplan J, Brem H.

Cancer Chemother Pharmacol. 2007 Oct;60(5):643-50. Epub 2007 Jan 26.

PMID:
17256133
9.

Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.

Yuan X, Tabassi K, Williams JA.

Radiat Oncol Investig. 1999;7(4):218-30.

PMID:
10492162
10.

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.

Brem H, Tamargo RJ, Olivi A, Pinn M, Weingart JD, Wharam M, Epstein JI.

J Neurosurg. 1994 Feb;80(2):283-90.

PMID:
8283268
11.

Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.

Yuan X, Dillehay LE, Williams JR, Williams JA.

Cancer Biother Radiopharm. 1999 Jun;14(3):187-202.

PMID:
10850303
12.

Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.

Williams JA, Dillehay LE, Tabassi K, Sipos E, Fahlman C, Brem H.

J Neurooncol. 1997 May;32(3):181-92.

PMID:
9049879
13.
14.

Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.

Frazier JL, Wang PP, Case D, Tyler BM, Pradilla G, Weingart JD, Brem H.

J Neurooncol. 2003 Sep;64(3):203-9.

PMID:
14558595
15.

Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

Walter KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Domb A, Brem H.

Cancer Res. 1994 Apr 15;54(8):2207-12.

16.

Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H.

Cancer Res. 1993 Jan 15;53(2):329-33.

17.

Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.

Allard E, Jarnet D, Vessières A, Vinchon-Petit S, Jaouen G, Benoit JP, Passirani C.

Pharm Res. 2010 Jan;27(1):56-64. doi: 10.1007/s11095-009-0006-0. Epub 2009 Nov 12.

PMID:
19908129
18.

Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.

Storm PB, Moriarity JL, Tyler B, Burger PC, Brem H, Weingart J.

J Neurooncol. 2002 Feb;56(3):209-17.

PMID:
12061726
19.

Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells.

Guo G, Fu S, Zhou L, Liang H, Fan M, Luo F, Qian Z, Wei Y.

Nanoscale. 2011 Sep 1;3(9):3825-32. doi: 10.1039/c1nr10484e. Epub 2011 Aug 17.

PMID:
21847493
20.

Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors.

Hanes J, Sills A, Zhao Z, Suh KW, Tyler B, DiMeco F, Brat DJ, Choti MA, Leong KW, Pardoll DM, Brem H.

Pharm Res. 2001 Jul;18(7):899-906.

PMID:
11496947
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk